Semaglutide and similar medications could be key players in bending the curve but enduring change ultimately hinges on a ...

The study followed nearly 17 million people, the majority of whom were in the 26-75 age range, and found that after climbing ...

If a medication shortage is making it difficult for you to access semaglutide through your typical doctor or pharmacy, the ...

Patients with type 2 diabetes who use semaglutide have more than double the risk of severe optic nerve damage than those who ...

The most-read obesity articles of 2024 mostly focused on insurance coverage of weight loss medications and costs.

Obesity rates in the US dropped slightly in 2023 for the first time in over a decade, with rates falling from 46% to 45.6%. A ...

Those treated with tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, lost on ...

Obesity and body mass index in the U.S. have decreased for the first time in more than a decade.

So, no matter your semaglutide dose, which type you’re taking, or whether you’re taking it for type 2 diabetes or obesity, ...

Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023.

Obesity prevalence in the US decreased in 2023, with significant drops in the South, highlighting the impact of GLP-1RA ...